A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
BackgroundPPARα and cyclooxygenase (COX)-2 are overexpressed in certain types of cancer. Thus, developing a dual inhibitor that targets both could be more effective as an anticancer agent than single inhibitors. We have previously shown that an analog of the bezafibrate named AA520 is a PPARα antago...
        Saved in:
      
    
          | Main Authors: | Alessandra Ammazzalorso, Stefania Tacconelli, Annalisa Contursi, Ulrika Hofling, Carmen Cerchia, Sara Di Berardino, Alessandra De Michele, Rosa Amoroso, Antonio Lavecchia, Paola Patrignani | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Frontiers Media S.A.
    
        2024-11-01 | 
| Series: | Frontiers in Pharmacology | 
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488722/full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    PPARα exacerbates Salmonella Typhimurium infection by modulating the immunometabolism and macrophage polarization        
                          
 by: Jessica R. Taddeo, et al.
 Published: (2024-12-01)
- 
                
                    Comparative Evaluation of Cyclooxygenase Inhibition Profiles Across Various NSAID Forms and Doses: Implications for Efficacy and Adverse Effects        
                          
 by: Kenshu Shirakawa, et al.
 Published: (2024-12-01)
- 
                
                    Long-chain polyunsaturated fatty acid-containing phosphatidylcholines predict survival rate in patients after heart failure        
                          
 by: Aleš Kvasnička, et al.
 Published: (2024-11-01)
- 
                
                    Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment        
                          
 by: Lixia Cheng, et al.
 Published: (2024-11-01)
- 
                
                    Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention        
                          
 by: Annalisa Contursi, et al.
 Published: (2024-12-01)
 
       